Inovio Pharma (INO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2017 | 03-2017 | 12-2016 | 09-2016 | 06-2016 | |
| Sales | 20,412 | 10,376 | 8,514 | 12,541 | 6,204 |
| Gross Profit | 20,412 | 10,376 | 8,514 | 12,541 | 6,204 |
| Operating Expenses | 30,048 | 32,310 | 30,877 | 32,736 | 24,430 |
| Operating Income | -9,636 | -21,934 | -22,363 | -20,196 | -18,227 |
| Other Income | 157 | -1,152 | -3,870 | -564 | -478 |
| Pre-tax Income | -9,479 | -23,086 | -26,234 | -20,759 | -18,705 |
| Net Income Continuous | -9,479 | -23,086 | -26,234 | -20,759 | -18,705 |
| Net Income | $-9,479 | $-23,086 | $-26,234 | $-20,759 | $-18,705 |
| EPS Basic Total Ops | -1.56 | -3.72 | -4.32 | -3.36 | -3.12 |
| EPS Basic Continuous Ops | -1.51 | -3.74 | -4.29 | -3.39 | -3.08 |
| EPS Diluted Total Ops | -1.56 | -3.72 | -4.32 | -3.36 | -3.12 |
| EPS Diluted Continuous Ops | -1.51 | -3.73 | -4.30 | -3.38 | -3.08 |
| EBITDA(a) | $-8,662 | $-20,936 | $-21,473 | $-19,257 | $-17,367 |